Since some cases of T2D primarily involve reduced insulin secretion, we analyzed the association between the TyG index and all-cause mortality in individuals not receiving insulin therapy who had fasting insulin levels below the median (< 5.54 μIU/mL, n = 230). This evidence concerns the gene INS and type 2 diabetes mellitus.